Immunocore Holdings Stock Analysis

Immunocore Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The book value of Immunocore Holdings was currently reported as 7.55. The company recorded a loss per share of 0.95. Immunocore Holdings had not issued any dividends in recent years. Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom. Immunocore Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 324 people. To learn more about Immunocore Holdings call Bahija Jallal at 44 12 3543 8600 or check out https://www.immunocore.com.

Immunocore Holdings Investment Alerts

Immunocore Holdings Upcoming and Recent Events

Immunocore Largest EPS Surprises

View All Earnings Estimates

Immunocore Holdings Environmental, Social, and Governance (ESG) Scores

Immunocore Stock Institutional Investors

Note, although Immunocore Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immunocore Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.61 B.

Immunocore Profitablity

The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11.

Management Efficiency

Immunocore Holdings has return on total asset (ROA) of (0.0522) % which means that it has lost $0.0522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1283) %, meaning that it created substantial loss on money invested by shareholders. Immunocore Holdings' management efficiency ratios could be used to measure how well Immunocore Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to drop to -0.1. In addition to that, Return On Capital Employed is likely to drop to -0.14. At this time, Immunocore Holdings' Net Tangible Assets are relatively stable compared to the past year. As of 11/22/2024, Non Currrent Assets Other is likely to grow to about 15.2 M, while Total Current Assets are likely to drop slightly above 270.4 M.

Technical Drivers

As of the 22nd of November, Immunocore Holdings retains the Risk Adjusted Performance of (0.04), market risk adjusted performance of (0.15), and Standard Deviation of 2.53. Immunocore Holdings technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Immunocore Holdings variance and potential upside to decide if Immunocore Holdings is priced fairly, providing market reflects its last-minute price of 32.12 per share. Given that Immunocore Holdings has information ratio of (0.11), we strongly advise you to confirm Immunocore Holdings's regular market performance to make sure the company can sustain itself at a future point.

Immunocore Holdings Price Movement Analysis

Immunocore Holdings Insider Trading Activities

Immunocore Holdings Outstanding Bonds

Immunocore Holdings Predictive Daily Indicators

Immunocore Holdings Corporate Filings

Immunocore Holdings Forecast Models

Immunocore Holdings' time-series forecasting models are one of many Immunocore Holdings' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immunocore Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immunocore Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immunocore shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immunocore Holdings. By using and applying Immunocore Stock analysis, traders can create a robust methodology for identifying Immunocore entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immunocore analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immunocore analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Immunocore Holdings stock analysis indicators help investors evaluate how Immunocore Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immunocore Holdings shares will generate the highest return on investment. By understating and applying Immunocore Holdings stock analysis, traders can identify Immunocore Holdings position entry and exit signals to maximize returns.

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.